Q2 2025 · 13F-HR
Indaba Capital Management, L.P.holdings as filed
Filed 2025-08-14 · accession 0001011438-25-000452
$135.4M
Reported value
10
Positions
2025-06-30
Period end
The Brief · Indaba Capital Management, L.P. · Q2 2025
AI · grounded in 13F
Indaba Capital Management, L.P. established a new position in BANDWIDTH INC [[stock:BAND 0.5 04/01/28]] valued at $33.8M. The fund also initiated new holdings in SUMMIT HOTEL PPTYS [[stock:INN 1.5 02/15/26]] for $28.1M and ON24 INC ONTF for $23M. Other new additions include IRONWOOD PHARMACEUTICALS INC [[stock:IRWD 1.5 06/15/26]] and TRAVERE THERAPEUTICS INC [[stock:TVTX 2.5 09/15/25]].
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 05988JAD5 | BAND 0.5 04/01/28 | BANDWIDTH INC | $33.8M | 24.9% | 40,250,000 | Common | SOLE |
| 866082AA8 | INN 1.5 02/15/26 | SUMMIT HOTEL PPTYS | $28.1M | 20.8% | 29,039,000 | Common | SOLE |
| 68339B104 | ONTF | ON24 INC | $23.0M | 17.0% | 4,240,256 | Common | SOLE |
| 46333XAH1 | IRWD 1.5 06/15/26 | IRONWOOD PHARMACEUTICALS INC | $14.4M | 10.7% | 17,000,000 | Common | SOLE |
| 761299AB2 | TVTX 2.5 09/15/25 | TRAVERE THERAPEUTICS INC | $12.8M | 9.49% | 13,000,000 | Common | SOLE |
| 09227Q100 | BLKB | BLACKBAUD INC | $12.4M | 9.15% | 193,000 | Common | SOLE |
| 047726302 | BATRK | ATLANTA BRAVES HLDGS INC | $4.4M | 3.24% | 93,811 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $3.0M | 2.18% | 3,000,000 | Common | SOLE |
| 29082K105 | EMBC | EMBECTA CORP | $2.2M | 1.59% | 221,938 | Common | SOLE |
| 00791N102 | — | ADVANTAGE SOLUTIONS INC | $1.3M | 0.96% | 980,865 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.